Isoflavones, phytoestrogens in soy beans with estrogen-like properties, have been examined for their cancer protective effects. Mammographic density is a strong predictor of breast cancer. This review summarizes studies that have examined the association between isoflavones and breast density. Observational investigations in Hawaii and Singapore suggest slightly lower breast density among women of Asian descent with regular soy intake, but two larger studies from Japan and Singapore did not observe a protective effect. The findings from seven randomized trials with primarily Caucasian women indicate that soy or isoflavones do not modify mammographic density. Soy foods and isoflavone supplements within a nutritional range do not appear to modify breast cancer risk as assessed by mammographic density.
References
[1]
Trock, B.J.; Hilakivi-Clarke, L.; Clarke, R. Meta-analysis of soy intake and breast cancer risk. J. Natl. Cancer Inst.？2006, 98, 459–471, doi:10.1093/jnci/djj102. 16595782
[2]
Wu, A.H.; Yu, M.C.; Tseng, C.C.; Pike, M.C. Epidemiology of soy exposures and breast cancer risk. Br. J. Cancer？2008, 98, 9–14, doi:10.1038/sj.bjc.6604145. 18182974
[3]
Shu, X.O.; Jin, F.; Dai, Q.; Wen, W.; Potter, J.D.; Kushi, L.H.; Ruan, Z.; Gao, Y.T.; Zheng, W. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol. Biomarkers Prev.？2001, 10, 483–488. 11352858
[4]
Wu, A.H.; Wan, P.; Hankin, J.; Tseng, C.C.; Yu, M.C.; Pike, M.C. Adolescent and adult soy intake and risk of breast cancer in Asian- Americans. Carcinogenesis？2002, 23, 1491–1496, doi:10.1093/carcin/23.9.1491. 12189192
[5]
United States Department of Agriculture USDA-Iowa State University Database on the Isoflavone Content of Foods. 2002. Available online: http://www.nal.usda.gov/fnic/foodcomp/Data/isoflav/ isoflav.html/ , accessed on January 11, 2010.
[6]
Adlercreutz, H.; Goldin, B.R.; Gorbach, S.L.; H？ckerstedt, K.A.V.; Watanabe, S.; H？m？l？inen, E.; Markkanen, M.H.; M？kel？, T.K.; W？h？l？m, K.T.; Hase, T.A.; Fotsis, T. Soybean phytoestrogen intake and cancer risk. J. Nutr.？1995, 125, 757S–770S. 7884562
[7]
Messina, M.; Nagata, C.; Wu, A.H. Estimated Asian adult soy protein and isoflavone intakes. Nutr. Cancer？2006, 55, 1–12, doi:10.1207/s15327914nc5501_1. 16965235
[8]
Tsunoda, N.; Pomeroy, S.; Nestel, P. Absorption in humans of isoflavones from soy and red clover is similar. J. Nutr.？2002, 132, 2199–2201. 12163662
[9]
McCarty, M.F. Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits. Med. Hypotheses？2006, 66, 1093–1114, doi:10.1016/j.mehy.2004.11.046. 16513288
[10]
Gallo, D.; Ferrandina, G.; Giacomelli, S.; Fruscella, E.; Zannoni, G.; Morazzoni, P.; Riva, A.; Bombardelli, E.; Mancuso, S.; Scambia, G. Dietary soy modulation of biochemical parameters in DMBA-induced mammary tumors. Cancer Lett.？2002, 186, 43–48, doi:10.1016/S0304-3835(02)00326-9. 12183074
[11]
Lazennec, G.; Bresson, D.; Lucas, A.; Chauveau, C.; Vignon, F. ER beta inhibits proliferation and invasion of breast cancer cells. Endocrinology？2001, 142, 4120–30, doi:10.1210/en.142.9.4120. 11517191
[12]
Fox, E.M.; Davis, R.J.; Shupnik, M.A. ERbeta in breast cancer--onlooker, passive player, or active protector? Steroids？2008, 73, 1039–1051, doi:10.1016/j.steroids.2008.04.006. 18501937
[13]
Lawson, J.S.; Field, A.S.; Tran, D.D.; Killeen, J.; Maskarinec, G.; Ishikura, H.; Trichopoulos, D. Breast cancer incidence and estrogen receptor alpha in normal mammary tissue--an epidemiologic study among Japanese women in Japan and Hawaii. Int. J. Cancer？2002, 97, 685–687, doi:10.1002/ijc.10093. 11807798
[14]
Messina, M.J.; Persky, V.; Setchell, K.D.; Barnes, S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer？1994, 21, 113–131, doi:10.1080/01635589409514310. 8058523
[15]
Messina, M.J.; Loprinzi, C.L. Soy for breast cancer survivors: a critical review of the literature. J. Nutr.？2001, 131, 3095S–3108S. 11694655
[16]
Loukovaara, M.; Carson, M.; Palotie, A.; Adlercreutz, H. Regulation of sex hormone-binding globulin production by isoflavonoids and patterns of isoflavonoid conjugation in HepG2 cell cultures. Steroids？1995, 60, 656–661, doi:10.1016/0039-128X(95)00089-9. 8545857
[17]
Adlercreutz, H.; Bannwart, C.; Wahala, K.; Makela, T.; Brunow, G.; Hase, T.; Arosemena, P.J.; Kellis, J.; Vickery, L.E. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J. Steroid Biochem. Mol. Biol.？1993, 44, 147–153, doi:10.1016/0960-0760(93)90022-O. 8382517
[18]
Makela, S.; Poutanen, M.; Lehtimaki, J.; Kostian, M.L.; Santti, R.; Vihko, R. Estrogen-specific 17β-hydroxysteroid oxidoreductase type I (E.C.1.1.1.62) as a possible target for the action of phytoestrogens. Proc. Soc. Exp. Biol. Med.？1995, 208, 51–59. 7892295
[19]
Rose, D.P. Dietary fiber and breast cancer. Nutr. Cancer？1990, 13, 1–8, doi:10.1080/01635589009514040. 2153951
[20]
Adlercreutz, H. Evolution, nutrition, intestinal microflora, and prevention of cancer: a hypothes. Proc. Soc. Exp. Biol. Med.？1998, 217, 241–246. 9492331
[21]
Barnes, S.; Boersma, B.; Patel, R.; Kirk, M.; Darley-Usmar, V.M.; Kim, H.; Xu, J. Isoflavonoids and chronic disease: mechanisms of action. Biofactors？2000, 12, 209–215, doi:10.1002/biof.5520120133. 11216488
[22]
Ford, D. Mechanistic explanations for the chemopreventive action of soyabean isoflavones: reducing the possibilities. Br. J. Nutr.？2002, 88, 439–441, doi:10.1079/BJN2002711. 12425724
[23]
Cotroneo, M.S.; Wang, J.; Fritz, W.A.; Eltoum, I.E.; Lamartiniere, C.A. Genistein action in the prepubertal mammary gland in a chemoprevention model. Carcinogenesis？2002, 23, 1467–1474, doi:10.1093/carcin/23.9.1467. 12189189
[24]
Russo, J.; Russo, I.H. Hormonally induced differentiation: a novel approach to breast cancer prevention. J. Cell. Biochem. Suppl.？1995, 22, 58–64. 8538211
[25]
Hilakivi-Clarke, L.; Onojafe, I.; Raygada, M.; Cho, E.; Skaar, T.; Russo, I.; Clarke, R. Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. Br. J. Cancer？1999, 80, 1682–1688, doi:10.1038/sj.bjc.6690584. 10468283
[26]
McCormack, V.A.; dos Santos Silva, I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev？2006, 15, 1159–1169, doi:10.1158/1055-9965.EPI-06-0034. 16775176
[27]
Wolfe, J.N. Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer？1976, 37, 2486–2492, doi:10.1002/1097-0142(197605)37:5<2486::AID-CNCR2820370542>3.0.CO;2-8. 1260729
[28]
Gram, I.T.; Funkhouser, E.; Tabar, L. Reproductive and menstrual factors in relation to mammographic parenchymal patterns among perimenopausal women. Br. J. Cancer？1995, 71, 647–650, doi:10.1038/bjc.1995.128. 7880753
[29]
Saftlas, A.F.; Hoover, R.N.; Brinton, L.A.; Szklo, M.; Olson, D.R.; Salane, M.; Wolfe, J.N. Mammographic densities and risk of breast cancer. Cancer？1991, 67, 2833–2838, doi:10.1002/1097-0142(19910601)67:11<2833::AID-CNCR2820671121>3.0.CO;2-U. 2025849
[30]
Byrne, C.; Schairer, C.; Wolfe, J.; Parekh, N.; Salane, M.; Brinton, L.A.; Hoover, R.; Haile, R. Mammographic features and breast cancer risk: effects with time, age, and menopause statu. J. Natl. Cancer Inst.？1995, 87, 1622–1629, doi:10.1093/jnci/87.21.1622. 7563205
Ursin, G.; Astrahan, M.A.; Salane, M.; Parisky, Y.R.; Pearce, J.G.; Daniels, J.R.; Pike, M.C.; Spicer, D.V. The detection of changes in mammographic densities. Cancer Epidemiol. Biomarkers Prev.？1998, 7, 43–47. 9456242
[33]
Boyd, N.F.; Rommens, J.M.; Vogt, K.; Lee, V.; Hopper, J.L.; Yaffe, M.J.; Paterson, A.D. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol.？2005, 6, 798–808, doi:10.1016/S1470-2045(05)70390-9. 16198986
[34]
Gram, I.T.; Bremnes, Y.; Ursin, G.; Maskarinec, G.; Bjurstam, N.; Lund, E. Percentage density, Wolfe's and Tabar's mammographic patterns: agreement and association with risk factors for breast cancer. Breast Cancer Res.？2005, 7, R854–R861, doi:10.1186/bcr1308. 16168132
[35]
Boyd, N.; Martin, L.; Gunasekara, A.; Melnichouk, O.; Maudsley, G.; Peressotti, C.; Yaffe, M.; Minkin, S. Mammographic density and breast cancer risk: evaluation of a novel method of measuring breast tissue volumes. Cancer Epidemiol. Biomarkers Prev.？2009, 18, 1754–1762, doi:10.1158/1055-9965.EPI-09-0107. 19505909
[36]
Highnam, R.; Pan, X.; Warren, R.; Jeffreys, M.; Davey, S.G.; Brady, M. Breast composition measurements using retrospective standard mammogram form (SMF). Phys. Med. Biol.？2006, 51, 2695–2713, doi:10.1088/0031-9155/51/11/001. 16723760
[37]
Martin, L.J.; Minkin, S.; Boyd, N.F. Hormone therapy, mammographic density, and breast cancer ris. Maturitas？2009, 64, 20–26, doi:10.1016/j.maturitas.2009.07.009. 19709825
[38]
Greendale, G.A.; Reboussin, B.A.; Slone, S.; Wasilauskas, C.; Pike, M.C.; Ursin, G. Postmenopausal hormone therapy and change in mammographic density. J. Natl. Cancer Inst.？2003, 95, 30–37, doi:10.1093/jnci/95.1.30. 12509398
[39]
McTiernan, A.; Martin, C.F.; Peck, J.D.; Aragaki, A.K.; Chlebowski, R.T.; Pisano, E.D.; Wang, C.Y.; Brunner, R.L.; Johnson, K.C.; Manson, J.E.; Lewis, C.E.; Kotchen, J.M.; Hulka, B.S. Estrogen-plus-progestin use and mammographic density in postmenopausal women: women's health initiative randomized trial. J. Natl. Cancer Inst.？2005, 97, 1366–1376, doi:10.1093/jnci/dji279. 16174858
[40]
Pike, M.C. The role of mammographic density in evaluating changes in breast cancer risk. Gynecol. Endocrinol.？2005, 21 Suppl 1, 1–5. 23327657
[41]
Rossouw, J.E.; Anderson, G.L.; Prentice, R.L.; LaCroix, A.Z.; Kooperberg, C.; Stefanick, M.L.; Jackson, R.D.; Beresford, S.A.; Howard, B.V.; Johnson, K.C.; Kotchen, J.M.; Ockene, J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA？2002, 288, 321–333, doi:10.1001/jama.288.3.321. 12117397
[42]
Spicer, D.V.; Ursin, G.; Parisky, Y.R.; Pearce, J.G.; Shoupe, D.; Pike, A.; Pike, M.C. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J. Natl. Cancer Inst.？1994, 86, 431–436, doi:10.1093/jnci/86.6.431. 8120917
[43]
Cuzick, J.; Warwick, J.; Pinney, E.; Warren, R.M.; Duffy, S.W. Tamoxifen and breast density in women at increased risk of breast cancer. J. Natl. Cancer Inst.？2004, 96, 621–628, doi:10.1093/jnci/djh106. 15100340
[44]
Freedman, M.; San Martin, J.; O'Gorman, J.; Eckert, S.; Lippman, M.E.; Lo, S.C.; Walls, E.L.; Zeng, J. Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placeb. J. Natl. Cancer Inst.？2001, 93, 51–56, doi:10.1093/jnci/93.1.51. 11136842
[45]
Becker, S.; Kaaks, R. Exogenous and endogenous hormones, mammographic density and breast cancer risk: can mammographic density be considered an intermediate marker of risk? Recent Results Cancer Res？2009, 181, 135–157. 19213565
[46]
Greendale, G.A.; Palla, S.L.; Ursin, G.; Laughlin, G.A.; Crandall, C.; Pike, M.C.; Reboussin, B.A. The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study. Am. J. Epidemiol.？2005, 162, 826–834, doi:10.1093/aje/kwi286. 16177147
[47]
Boyd, N.F.; Stone, J.; Martin, L.J.; Jong, R.; Fishell, E.; Yaffe, M.; Hammond, G.; Minkin, S. The association of breast mitogens with mammographic densities. Br. J. Cancer？2002, 87, 876–882, doi:10.1038/sj.bjc.6600537. 12373602
[48]
Tamimi, R.M.; Byrne, C.; Colditz, G.A.; Hankinson, S.E. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J. Natl. Cancer Inst.？2007, 99, 1178–1187, doi:10.1093/jnci/djm062. 17652278
[49]
Verheus, M.; Peeters, P.H.; Van Noord, P.A.; van der Schouw, Y.T.; Grobbee, D.E.; van Gils, C.H. No relationship between circulating levels of sex steroids and mammographic breast density: the Prospect-EPIC cohort. Breast Cancer Res.？2007, 9, R53, doi:10.1186/bcr1758. 17692133
[50]
Noh, J.J.; Maskarinec, G.; Pagano, I.; Cheung, L.W.; Stanczyk, F.Z. Mammographic densities and circulating hormones: a cross-sectional study in premenopausal women. Breast？2006, 15, 20–28, doi:10.1016/j.breast.2005.04.014. 16000251
[51]
Maskarinec, G.; Meng, L. An investigation of soy intake and mammographic characteristics in Hawaii. Breast Cancer Res.？2001, 3, 134–141, doi:10.1186/bcr285. 11250760
[52]
Nagel, G.; Mack, U.; von, F.D.; Linseisen, J. Dietary phytoestrogen intake and mammographic density -- results of a pilot study. Eur. J. Med. Res.？2005, 10, 389–394. 16183551
[53]
Jakes, R.W.; Duffy, S.W.; Ng, F.C.; Gao, F.; Ng, E.H.; Seow, A.; Lee, H.P.; Yu, M.C. Mammographic parenchymal patterns and self-reported soy intake in Singapore Chinese women. Cancer Epidemiol. Biomarkers Prev.？2002, 11, 608–613. 12101107
[54]
Ursin, G.; Sun, C.L.; Koh, W.P.; Khoo, K.S.; Gao, F.; Wu, A.H.; Yu, M.C. Associations between soy, diet, reproductive factors, and mammographic density in Singapore Chinese women. Nutr. Cancer？2006, 56, 128–135, doi:10.1207/s15327914nc5602_2. 17474857
[55]
Nagata, C.; Matsubara, T.; Fujita, H.; Nagao, Y.; Shibuya, C.; Kashiki, Y.; Shimizu, H. Associations of mammographic density with dietary factors in Japanese women. Cancer Epidemiol. Biomarkers Prev.？2005, 14, 2877–2880, doi:10.1158/1055-9965.EPI-05-0160. 16365004
[56]
Wu, A.H.; Ursin, G.; Koh, W.P.; Wang, R.; Yuan, J.M.; Khoo, K.S.; Yu, M.C. Green tea, soy, and mammographic density in Singapore Chinese women. Cancer Epidemiol. Biomarkers Prev.？2008, 17, 3358–3365, doi:10.1158/1055-9965.EPI-08-0132. 19064551
[57]
Maskarinec, G.; Pagano, I.; Lurie, G.; Kolonel, L.N. A longitudinal investigation of mammographic density: the multiethnic cohort. Cancer Epidemiol. Biomarkers Prev.？2006, 15, 732–739, doi:10.1158/1055-9965.EPI-05-0798. 16614116
[58]
Maskarinec, G.; Williams, A.E.; Carlin, L. Mammographic densities in a one-year isoflavone intervention. Eur. J. Cancer Prev.？2003, 12, 165–169, doi:10.1097/00008469-200304000-00011. 12671541
[59]
Maskarinec, G.; Takata, Y. ; Franke, A.A.; Williams, A.E.; Murphy, S.P. A 2-year soy intervention in premenopausal women does not change mammographic densities. J. Nutr.？2004, 134, 3089–3094. 15514280
[60]
Atkinson, C.; Warren, R.M.; Sala, E.; Dowsett, M.; Dunning, A.M.; Healey, C.S.; Runswick, S.; Day, N.E.; Bingham, S.A. Red clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]. Breast Cancer Res.？2004, 6, R170–R179, doi:10.1186/bcr773. 15084240
[61]
Marini, H.; Bitto, A.; Altavilla, D.; Burnett, B.P.; Polito, F.; Di, S.V; Minutoli, L.; Atteritano, M.; Levy, R.M.; D'Anna, R.; Frisina, N.; Mazzaferro, S.; Cancellieri, F.; Cannata, M.L.; Corrado, F.; Frisina, A.; Adamo, V.; Lubrano, C.; Sansotta, C.; Marini, R.; Adamo, E.B.; Squadrito, F. Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study. J. Clin. Endocrinol. Metab？2008, 93, 4787–4796. 18796517
[62]
Maskarinec, G.; Verheus, M.; Steinberg, F.M.; Amato, P.; Cramer, M.K.; Lewis, R.D.; Murray, M.J.; Young, R.L.; Wong, W.W. Various doses of soy isoflavones do not modify mammographic density in postmenopausal women. J. Nutr.？2009, 139, 981–986, doi:10.3945/jn.108.102913. 19321587
[63]
Verheus, M.; van Gils, C.H.; Kreijkamp-Kaspers, S.; Kok, L.; Peeters, P.H.; Grobbee, D.E.; van der Schouw, Y.T. Soy protein containing isoflavones and mammographic density in a randomized controlled trial in postmenopausal women. Cancer Epidemiol. Biomarkers Prev.？2008, 17, 2632–2638, doi:10.1158/1055-9965.EPI-08-0344. 18843004
[64]
Powles, T.J.; Howell, A.; Evans, D.G.; McCloskey, E.V.; Ashley, S.; Greenhalgh, R.; Affen, J.; Flook, L.A.; Tidy, A. Red clover isoflavones are safe and well tolerated in women with a family history of breast cancer. Menopause. Int.？2008, 14, 6–12, doi:10.1258/mi.2007.007033. 18380954
[65]
Kataoka, M.; Atkinson, C.; Warren, R.; Sala, E.; Day, N.E.; Highnam, R.; Warsi, I.; Bingham, S.A. Mammographic density using two computer-based methods in an isoflavone trial. Maturitas？2008, 59, 350–357, doi:10.1016/j.maturitas.2008.03.005. 18495387
[66]
Vachon, C.M.; Pankratz, V.S.; Scott, C.G.; Maloney, S.D.; Ghosh, K.; Brandt, K.R.; Milanese, T.; Carston, M.J.; Sellers, T.A. Longitudinal trends in mammographic percent density and breast cancer risk. Cancer Epidemiol. Biomarkers Prev.？2007, 16, 921–928, doi:10.1158/1055-9965.EPI-06-1047. 17507617
[67]
Setchell, K.D.; Brown, N.M.; Lydeking-Olsen, E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J. Nutr.？2002, 132, 3577–3584. 12468591
[68]
Frankenfeld, C.L.; McTiernan, A.; Aiello, E.J.; Thomas, W.K.; LaCroix, K.; Schramm, J.; Schwartz, S.M.; Holt, V.L.; Lampe, J.W. Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women. Cancer Epidemiol. Biomarkers Prev.？2004, 13, 1156–1162. 15247126
[69]
Fuhrman, B.J.; Teter, B.E.; Barba, M.; Byrne, C.; Cavalleri, A.; Grant, B.J.; Horvath, P.J.; Morelli, D.; Venturelli, E.; Muti, P.C. Equol status modifies the association of soy intake and mammographic density in a sample of postmenopausal women. Cancer Epidemiol. Biomarkers Prev.？2008, 17, 33–42, doi:10.1158/1055-9965.EPI-07-0193. 18199709
[70]
Tamimi, R.M.; Hankinson, S.E.; Colditz, G.A.; Byrne, C. Endogenous sex hormone levels and mammographic density among postmenopausal women. Cancer Epidemiol. Biomarkers Prev.？2005, 14, 2641–2647, doi:10.1158/1055-9965.EPI-05-0558. 16284390
[71]
Boyd, N.F.; Martin, L.J.; Li, Q.; Sun, L.; Chiarelli, A.M.; Hislop, G.; Yaffe, M.J.; Minkin, S. Mammographic density as a surrogate marker for the effects of hormone therapy on risk of breast cancer. Cancer Epidemiol Biomarkers Prev？2006, 15, 961–966, doi:10.1158/1055-9965.EPI-05-0762. 16702377
[72]
Boyd, N.F.; Martin, L.J.; Sun, L.; Guo, H.; Chiarelli, A.; Hislop, G.; Yaffe, M.; Minkin, S. Body size, mammographic density, and breast cancer risk. Cancer Epidemiol. Biomarkers Prev.？2006, 15, 2086–2092, doi:10.1158/1055-9965.EPI-06-0345. 17119032
[73]
Izumi, T.; Piskula, M.K.; Osawa, S.; Obata, A.; Tobe, K.; Saito, M.; Kataoka, S.; Kubota, Y.; Kikuchi, M. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J. Nutr.？2000, 130, 1695–1699. 10867038
[74]
Zhan, S.; Ho, S.C. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am. J. Clin. Nutr.？2005, 81, 397–408. 15699227
[75]
Petrakis, N.L.; Barnes, S.; King, E.B.; Lowenstein, J.; Wiencke, J.; Lee, M.M.; Miike, R.; Kirk, M.; Coward, L. Stimulatory influence of soy protein isolate on breast secretion in pre-and postmenopausal women. Cancer Epidemiol. Biomarkers Prev.？1996, 5, 785–794. 8896889
[76]
Hargreaves, D.F.; Potten, C.S.; Harding, C.; Shaw, L.E.; Morton, M.S.; Roberts, S.A.; Howell, A.; Bundred, N.J. Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J. Clin. Endocrinol. Metab？1999, 84, 4017–4024, doi:10.1210/jc.84.11.4017. 10566643
[77]
Shu, X.O.; Zheng, Y.; Cai, H.; Gu, K.; Chen, Z.; Zheng, W.; Lu, W. Soy food intake and breast cancer survival. JAMA？2009, 302, 2437–2443, doi:10.1001/jama.2009.1783. 19996398
[78]
Boyd, N.; Martin, L.; Chavez, S.; Gunasekara, A.; Salleh, A.; Melnichouk, O.; Yaffe, M.; Friedenreich, C.; Minkin, S.; Bronskill, M. Breast-tissue composition and other risk factors for breast cancer in young women: a cross-sectional study. Lancet Oncol.？2009, 10, 569–580, doi:10.1016/S1470-2045(09)70078-6. 19409844
[79]
Glide, C.; Duric, N.; Littrup, P. Novel approach to evaluating breast density utilizing ultrasound tomography. Med. Phys.？2007, 34, 744–753, doi:10.1118/1.2428408. 17388192
[80]
Shepherd, J.A.; Malkov, S.; Fan, B.; Laidevant, A.; Novotny, R.; Maskarinec, G. Breast density assessment in adolescent girls using dual-energy X-ray absorptiometry: a feasibility study. Cancer Epidemiol. Biomarkers Prev.？2008, 17, 1709–1713, doi:10.1158/1055-9965.EPI-08-0006. 18628421
